MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG

Journal of Mass Spectrometry

Volumn 52, Issue 6, 2017, Pages 372-377

  Palmigiano, A ^a   Bua, R O ^a   Barone, R ^a,b   Rymen, D ^c,d   Regal L ^e   Deconinck, N ^f   Dionisi Vici, C ^g   Fung, C W ^h   Garozzo, D ^a   Jaeken, J ^d   Sturiale, L ^a  

^a CNR   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

apoC III IEF; COG5 CDG; MALDI TOF; N glycosylation; O glycosylation

Indexed keywords

BODY FLUIDS; COPYRIGHTS; DIAGNOSIS; ELECTROPHORESIS; POLYSACCHARIDES;

APOC-III IEF; COG5-CDG; MALDI-TOF; N-GLYCOSYLATION; O-GLYCOSYLATION;

GLYCOSYLATION;

APOLIPOPROTEIN C3; GLYCAN; GLYCOCONJUGATE; MANNOSE; TRANSFERRIN; BIOLOGICAL MARKER; COG5 PROTEIN, HUMAN; POLYSACCHARIDE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; FUCOSYLATION; GLYCOSYLATION; GOLGI COMPLEX; HIGH THROUGHPUT SCREENING; HUMAN; ISOELECTRIC FOCUSING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; PRIORITY JOURNAL; SIALYLATION; TRANSFERRIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CHILD; PROCEDURES;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CONGENITAL DISORDERS OF GLYCOSYLATION; GLYCOSYLATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85021075132     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.3936     Document Type: Article

References (25)

1. J. Jaeken. Congenital disorders of glycosylation. Handb. Clin. Neurol. 2013, 113, 1737.
2. H. H. Freeze, J. X. Chong, M. J. Bamshad, B. G. Ng. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 2014, 94, 161.
3. T. Oka, D. Ungar, F. M. Hughson, M. Krieger. The COG and COPI complexes interact to control the abundance of GEARs, a subset of Golgi integral membrane proteins. Mol. Biol. Cell 2004, 15, 2423.
4. V. J. Miller, D. Ungar. Re'COG'nition at the Golgi. Traffic 2012, 13, 891.
5. S. Potelle, A. Klein, F. Foulquier. Golgi post-translational modifications and associated diseases. J. Inherit. Metab. Dis. 2015, 38, 741.
6. D. Rymen, J. Winter, P. M. Van Hasselt, J. Jaeken, C. Kasapkara, G. Gokçay, H. Haijes, P. Goyens, A. Tokatli, C. Thiel, O. Bartsch, J. Hecht, P. Krawitz, H. C. Prinsen, E. Mildenberger, G. Matthijs, U. Kornak. Key features and clinical variability of COG6-CDG. Mol. Genet. Metab. 2015, 116, 163.
7. J. Lübbehusen, C. Thiel, N. Rind, D. Ungar, B. H. Prinsen, T. J. de Koning, P. M. van Hasselt, C. Körner. Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. Hum. Mol. Genet. 2010, 19, 3623.
8. X. Wu, R. A. Steet, R. A. O. Bohorov, J. Bakker, J. Newell, M. Krieger, L. Spaapen, S. Kornfeld, H. H. Freeze. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat. Med. 2004, 10, 518.
9. F. Foulquier, E. Vasile, E. Schollen, N. Callewaert, T. Raemaekers, D. Quelhas, J. Jaeken, P. Mills, B. Winchester, M. Krieger, W. Annaert, G. Matthijs. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 3764.
10. E. Reynders, F. Foulquier, E. Leão Teles, D. Quelhas, W. Morelle, C. Rabouille, W. Annaert, G. Matthijs. Golgi function and dysfunction in the first COG4-deficient CDG type II patient. Hum. Mol. Genet. 2009, 18, 3244.
11. C. W. Fung, G. Matthijs, L. Sturiale, D. Garozzo, K. Y. Wong, R. Wong, V. Wong, J. Jaeken. COG5-CDG with a Mild Neurohepatic Presentation. JIMD Rep. 2012, 3, 67.
12. S. Wopereis, S. Grünewald, E. Morava, J. M. Penzien, P. Briones, M. T. García-Silva, P. N. Demacker, K. M. Huijben, R. A. Wevers. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin. Chem. 2003, 49, 1839.
13. M. E. del Castillo Busto, M. Montes-Bayón, E. Blanco-González, J. Meija, A. Sanz-Medel. Strategies to study human serum transferrin isoforms using integrated liquid chromatography ICPMS, MALDI-TOF, and ESI-Q-TOF detection: application to chronic alcohol abuse. Anal. Chem. 2005, 77, 5615.
14. R. W. Mahley, T. L. Innerarity, S. C. Jr Rall, K. H. Weisgraber. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 1984, 25, 1277.
15. P. V. Bondarenko, S. L. Cockrill, L. K. Watkins, I. D. Cruzado, R. D. Macfarlane. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res. 1999, 40, 543.
16. Y. Wada, M. Kadoya, N. Okamoto. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient. Glycobiology 2012, 22, 1140.
17. S. Yen-Nicolaÿ, C. Boursier, M. Rio, D. J. Lefeber, A. Pilon, N. Seta, A. Bruneel. MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis. Proteomics Clin. Appl. 2015, 9, 787.
18. S. B. Harvey, Y. Zhang, J. Wilson-Grady, T. Monkkonen, G. L. Nelsestuen, R. S. Kasthuri, M. R. Verneris, T. C. Lund, E. W. Ely, G. R. Bernard, H. Zeisler, M. Homoncik, B. Jilma, T. Swan, T. A. Kellogg. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J. Proteome Res. 2009, 8, 603.
19. D. Rymen, L. Keldermans, V. Race, L. Régal, N. Deconinck, C. Dionisi-Vici, C. W. Fung, L. Sturiale, C. Rosnoblet, F. Foulquier, G. Matthijs, J. Jaeken. COG5-CDG: expanding the clinical spectrum. Orphanet J. Rare Dis. 2012, 7, 94.
20. I. Ciucanu, F. Kerek. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 1984, 131, 209.
21. L. Sturiale, R. Barone, D. Garozzo. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation. J. Inherit. Metab. Dis. 2011, 34, 891.
22. A. Ceroni, K. Maass, H. Geyer, R. Geyer, A. Dell, S. M. Haslam. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J. Proteome Res. 2008, 7, 1650.
23. N. Ondrušková, T. Honzík, J. Kytnarová, M. Matoulek, J. Zeman, H. Hansíková. Isoelectric focusing of serum apolipoprotein C-III as a sensitive screening method for the detection of O-glycosylation disturbances. Prague Med. Rep. 2015, 116, 73.
24. P. Paesold-Burda, C. Maag, H. Troxler, F. Foulquier, P. Kleinert, S. Schnabel, M. Baumgartner, T. Hennet. Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. Hum. Mol. Genet. 2009, 18, 4350.
25. B. Xia, W. Zhang, X. Li, R. Jiang, T. Harper, R. Liu, R. D. Cummings, M. He. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation. Anal. Biochem. 2013, 442, 178.